A Study to Evaluate ONM-100, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer

Conditions:   Breast Cancer;   Head and Neck Squamous Cell Carcinoma;   Colorectal Cancer;   Bladder Cancer;   Prostate Cancer;   Ovarian Cancer
Intervention:   Drug: ONM-100
Sponsor:   OncoNano Medicine, Inc.
Not yet recruiting

https://ift.tt/2QsoWiF